Trxade Group Inc. (NASDAQ: MEDS) Uplists to Nasdaq, Expects Gross Proceeds of $5.2M from Common Stock Sale
Trxade announces pricing of a firm commitment public offering of 806,452 shares of its common stock Proceeds to be used as working capital and to fund future acquisitions Company’s B2B online purchasing platform currently has 11,900 pharmacies registered and is registering 100+ New pharmacies per month Trxade Group Inc. (NASDAQ: MEDS), an integrated drug delivery, … Continue reading “Trxade Group Inc. (NASDAQ: MEDS) Uplists to Nasdaq, Expects Gross Proceeds of $5.2M from Common Stock Sale”